跳至主要内容
临床试验/EUCTR2020-005875-10-BG
EUCTR2020-005875-10-BG进行中(未招募)1 期

An Extension Study to Evaluate the Long-Term Outcomes of Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study - BUTTERFLEYE NEXT

Regeneron Pharmaceuticals. Inc.0 个研究点目标入组 112 人开始时间: 2021年12月3日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
112

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • •Key Inclusion Criteria:
  • •1. Patient was treated in study VGFTe-ROP-1920
  • •2. Age <13 months of chronological age
  • •3. Signed informed consent from parent(s)/legal guardian(s), which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range: 112
  • •F.1.2 Adults (18-64 years) no
  • •F.1.2.1 Number of subjects for this age range
  • •F.1.3 Elderly (>=65 years) no
  • •F.1.3.1 Number of subjects for this age range

排除标准

  • •1. Patient has a condition preventing participation in the study, or performance of study

研究者

发起方
Regeneron Pharmaceuticals. Inc.

相似试验

进行中(未招募)
1 期
Extension study to evaluate the long-term outcomes of subjects in study 20090MedDRA version: 20.1 Level: PT Classification code 10038933 Term: Retinopathy of prematurity System Organ Class: 10015919 - Eye disordersRetinopathy of prematurity
EUCTR2018-003180-54-ESBayer AG102
进行中(未招募)
1 期
Extension study to evaluate the long-term outcomes of subjects in study 20090MedDRA version: 20.1 Level: PT Classification code 10038933 Term: Retinopathy of prematurity System Organ Class: 10015919 - Eye disordersRetinopathy of prematurity
EUCTR2018-003180-54-GBBayer AG102
进行中(未招募)
1 期
Extension study to evaluate the long-term outcomes of subjects in study 20090MedDRA version: 20.1 Level: PT Classification code 10038933 Term: Retinopathy of prematurity System Organ Class: 10015919 - Eye disordersRetinopathy of prematurity
EUCTR2018-003180-54-HUBayer AG102
进行中(未招募)
1 期
Extension study to evaluate the long-term outcomes of subjects in study 20090MedDRA version: 20.1Level: PTClassification code 10038933Term: Retinopathy of prematuritySystem Organ Class: 10015919 - Eye disordersRetinopathy of prematurity
EUCTR2018-003180-54-PTBayer AG102
进行中(未招募)
1 期
Extension study to evaluate the long-term outcomes of subjects in study 20090MedDRA version: 20.1 Level: PT Classification code 10038933 Term: Retinopathy of prematurity System Organ Class: 10015919 - Eye disordersRetinopathy of prematurity
EUCTR2018-003180-54-DEBayer AG102